*Trypanosoma brucei, Trypanosoma congolense* and *Trypanosoma vivax* are African trypanosome species that can infect game animals and livestock, with a co-infection frequency of up to 25% where analysed[@R4]--[@R7]. All three species are spread by tsetse flies but undergo distinctive developmental paths within the arthropod vector[@R8]. Furthermore, only *Trypanosoma brucei* is reported to undergo developmental transformation in the bloodstream of mammalian hosts in preparation for transmission, generating 'stumpy forms' that are G1 arrested and morphologically distinct from 'slender forms' that proliferate to establish each wave of parasitaemia[@R9]. Other trypanosome species are described as monomorphic, or have ill-defined morphological heterogeneity in the historical literature[@R10]--[@R12], although *T. vivax* can accumulate in a G1 arrested form[@R13]. To determine whether *T. congolense* exhibits density dependent cell-cycle arrest in the mammalian bloodstream, six mice infected with *T. congolense* ILTat3000 were monitored for their kinetoplast (K) and nuclear (N) configuration[@R14], a cytological indicator of cell cycle position. Analysis over the first 14 days of infection demonstrated that parasite number had a significant negative effect on the proportion of proliferating (2K1N, 2K2N) cells (general linear model, p=0.001) ([Figure 1a](#F1){ref-type="fig"}) such that parasites accumulated with a 1K1N configuration in individual infections when their numbers exceeded approximately 8x10^7^/ml ([Supplementary Figure 1](#SD2){ref-type="supplementary-material"}). Although this was not associated with an accompanying morphological transition equivalent to *T. brucei* stumpy formation ([Figure 1b-d](#F1){ref-type="fig"}), BLAST and reciprocal BLAST analysis of the genome of *T. congolense* identified potential orthologues of a characterised set of 25 *T. brucei* genes required for stumpy formation[@R15] ([Supplementary Table 1](#SD2){ref-type="supplementary-material"}), there being a similar number in the *T. vivax* genome. Hence *T. congolense* demonstrated density-dependent cell-cycle arrest *in vivo* and encodes predicted orthologues of components of the *T. brucei* stumpy formation pathway.

To explore conservation of the signalling pathway responsible for stumpy formation between *T. congolense* and *T. brucei*, functional complementarity was examined ([Figure 2](#F2){ref-type="fig"}). Null mutants for *Tb*927.9.4080 ('*Tb*HYP2', previously identified as a component of the *T. brucei* QS response pathway[@R15]; [Supplementary table 2](#SD2){ref-type="supplementary-material"} and [Supplementary Figure 2](#SD2){ref-type="supplementary-material"}) were initially generated in pleomorphic *T. brucei* EATRO 1125 by sequential allelic replacement (*T. brucei* AnTat1.1 90:13 Δ*Tb*HYP2; [Supplementary Figure 3](#SD2){ref-type="supplementary-material"}). As expected for a QS signalling pathway component, *Tb*HYP2 null mutants lost the capacity for growth control *in vivo* ([Supplementary Figure 4](#SD2){ref-type="supplementary-material"}). They also did not express the PAD1 marker for stumpy forms[@R16] ([Supplementary Figure 4](#SD2){ref-type="supplementary-material"}) and, when harvested and exposed to the developmental trigger cis-aconitate, differentiated to the next life-cycle stage (procyclic forms) less efficiently than wild type parasites as assessed by expression of the procyclic surface protein EP procyclin and proliferation ([Supplementary Figure 4](#SD2){ref-type="supplementary-material"}). Thereafter, the *Tb*HYP2 null mutants were engineered ([Figure 2a](#F2){ref-type="fig"}) for doxycycline-inducible ectopic expression of the *T. congolense* orthologue of *Tb*HYP2 (*Tc*IL3000.0.19510, '*Tc*HYP2'; E value: 5.9e-262, 45% identity, 58% similarity to *Tb*HYP2; [Supplementary Table 1](#SD2){ref-type="supplementary-material"}). [Figure 2b](#F2){ref-type="fig"} shows that upon inducible expression of *Tc*HYP2, there was slowed progression of the parasitaemia *in vivo*, potentially linked to either a premature development to stumpy forms caused by overexpression of the QS-signal pathway orthologue or a dominant negative consequence of *Tc*HYP2 expression. Supporting the former, those parasites induced to express *Tc*HYP2 exhibited PAD1 expression, whilst uninduced parasites remained PAD1 negative ([Figure 2c](#F2){ref-type="fig"}). Further, when exposed to cis-aconitate the induced parasites expressed EP procyclin more effectively than the uninduced lines after 4h and 24h ([Figure 2d](#F2){ref-type="fig"}; p\<0.0001 and p=0.0082 respectively). Combined these assays demonstrated that *Tc*HYP2 can restore stumpy formation in a *T. brucei Tb*HYP2 null mutant, demonstrating functional complementarity between the genes.

Next, to explore interspecies cross talk in QS signals, the capacity for *T. congolense* to release a signal capable of inducing stumpy formation in *T. br*ucei was tested. Initially, pleomorphic *T. brucei* (EATRO 1125 AnTat1.1 90:13; capable of stumpy formation), monomorphic *T. brucei* (Lister 427 cells; incapable of stumpy formation) or culture-adapted *T. congolense* cells (ILTat3000) were incubated in the presence of 50% or 75% conditioned medium from *T. congolense* culture (harvested from a *T. congolense* culture that had proliferated to 6x10^6^/ml after 3 days without passage). These parasite species grow optimally in different culture media but *T. brucei* can grow effectively in *Tc*N medium (75% *Tc*BSF3 *T. congolense* growth medium[@R17] plus 25% HMI-9 *T. brucei* culture medium[@R18]). [Supplementary Figure 5a](#SD2){ref-type="supplementary-material"} demonstrates that *T. congolense* grew uninterrupted in the presence of its own conditioned medium ('*Tc*CM'), demonstrating it could still support active proliferation uninhibited by the accumulation of toxic metabolites. In contrast, *T. brucei* showed reduced growth with *Tc*CM, this being more pronounced with the pleomorphic line than the monomorphic line ([Supplementary Figure 5b, 5c](#SD2){ref-type="supplementary-material"}). To assess whether this reflected a progression to stumpy formation in pleomorphic cells, a reporter line was exploited with the chloramphenicol acetyl transferase (CAT) gene expressed under the control of the PAD1 3'UTR that governs its stumpy-specific gene expression[@R19]. In this case, *Tc*CM reduced growth ([Figure 3a](#F3){ref-type="fig"}) and generated a 2.1fold (p=0.0002) increase in activation of the CAT reporter after 2 days compared to *Tc*N, equivalent to the activation generated by *T. brucei* AnTat1.1 90:13 conditioned medium (*Tb*CM; 1.9-fold, p=0.0006) ([Figure 3b](#F3){ref-type="fig"}). To explore whether the CAT-reporter response was mediated via the QS-signalling pathway, the same analysis was carried out using a cell line containing the CAT-PAD 3'UTR reporter construct but which was also capable of inducible RNAi of *Tb*HYP2 (*T. brucei* AnTat1.1 90:13 CAT-PAD *Tb*HYP2 RNAi). When exposed to conditioned medium from *T. brucei* (*Tb*CM, [Figure 3c](#F3){ref-type="fig"}) or *T. congolense* (*Tc*CM, [Figure 3d](#F3){ref-type="fig"}) for 48h and 72h, CAT reporter expression was significantly reduced upon *Tb*HYP2 RNAi compared to cells where *Tb*HYP2 RNAi was not induced (*Tc*CM at 48h, p=0.0009; *Tb*CM at 48h, p\<0.0001). Cell cycle arrest in response to *Tb*CM and *Tc*CM was also reduced upon *Tb*HYP2 RNAi ([Supplementary Figure 6](#SD2){ref-type="supplementary-material"}). Confirming this was mediated through a QS response, a CAT reporter controlled by the 3'UTR of the constitutively-expressed *T. brucei* aldolase gene was not significantly affected by *Tb*HYP2 RNAi when exposed to *Tb*CM or a cell permeable mimic of the QS signal, 8-pCPT-cAMP[@R20] ([Supplementary Figure 7](#SD2){ref-type="supplementary-material"}). Hence, *T. congolense* conditioned medium, as well as *T. brucei* conditioned medium, can promote growth arrest and activation of stumpy reporter gene expression in pleomorphic *T. brucei in vitro*, this being mediated through the QS signalling pathway. In contrast, culture-adapted *T. congolense* did not show growth inhibition in *T. brucei* conditioned medium containing QS-signal activity sufficient to arrest *T. brucei* ([Supplementary Figure 5d, 5e](#SD2){ref-type="supplementary-material"}). It remains to be established whether *T. congolense* are not responsive to the *T. brucei* QS-signal or if this is a consequence of the culture-adapted *T. congolense* line used in the *in vitro* experiments, which have been subject to long term passage. Unlike *T. brucei* conditioned medium, 8-pCPT-cAMP could inhibit *T. congolense* growth *in vitro*, supporting the conservation of a QS signalling pathway between the species, although the effect was less pronounced than with *T. brucei* ([Supplementary Figure 5f, 5g](#SD2){ref-type="supplementary-material"}).

Having demonstrated the potential for cross-talk in QS signals between *T. congolense* and *T. brucei in vitro*, we examined whether the same response was detectable in co-infections between these species *in vivo*. To enable unambiguous identification of *T. brucei* in the mixed infection, we generated a *T. brucei* pleomorphic line encoding a Ty1 epitope tagged PFRA protein (*T. brucei* AnTat1.1 90:13 PFR-Ty1)[@R21]. This allowed flagellar staining to distinguish *T. brucei* from *T. congolense*, with simultaneous co-labelling with PAD1 antibody and morphological analysis permitting quantitation of stumpy formation ([Figure 4a](#F4){ref-type="fig"}). Infections were initiated with *T. congolense* followed, on day 4 post-infection, with a super-infection with *T. brucei* ([Supplementary Figure 8a](#SD2){ref-type="supplementary-material"}). Control infections involving either *T. congolense* or *T. brucei* alone were analysed in parallel. The contribution of each species to the overall parasite load was then determined by scoring cell number and PFR labelling ([Figure 4b](#F4){ref-type="fig"}), as was *T. brucei* PAD1 expression ([Figure 4c](#F4){ref-type="fig"}) and cell-cycle status ([Supplementary Figure 9](#SD2){ref-type="supplementary-material"}). In the presence of a co-infection with *T. congolense, T. brucei* generated more PAD1-positive cells at a lower overall density of *T. brucei* than in *T. brucei* infections alone ([Figure 4c](#F4){ref-type="fig"}). Thus, 50% of *T. brucei* cells were PAD1-positive in the co-infection compared with \<10% in the mono-infection (p=0.0044), despite the *T. brucei* parasites comprising only a small proportion of the total parasite load, which was similar in the single species and mixed species infections (1x10^8^ cells/ml; [Supplementary Figure 8a](#SD2){ref-type="supplementary-material"}). Furthermore, although comprising only a minority of the overall parasitaemia in the co-infection ([Figure 4b](#F4){ref-type="fig"}), the *T. brucei* parasites had assumed a stumpy morphology and exhibited an accumulation of cells with a 1 kinetoplast, 1 nucleus configuration (p=0.015; [Supplementary Figure 9](#SD2){ref-type="supplementary-material"}). To confirm that *T. brucei* stumpy formation was mediated via the QS-signalling pathway, co-infection was repeated using a PFR-epitope tagged *T. brucei* line capable of RNAi-mediated silencing of *Tb*HYP2 under doxycycline regulation *(T. brucei* AnTat1.1 90:13 PFR-Ty1 *Tb*HYP2 RNAi). Effective *Tb*HYP2 silencing in this cell line was confirmed at the RNA level ([Figure 4d](#F4){ref-type="fig"}), this being expected to inhibit differentiation to stumpy forms *in vivo*. When co-infected with *T. congolense* ([Supplementary Figure 8b](#SD2){ref-type="supplementary-material"}, [Figure 4e](#F4){ref-type="fig"}), in the absence of *Tb*HYP2 silencing, *T. brucei* stumpy formation was accelerated ([Figure 4f](#F4){ref-type="fig"}) confirming the outcome with *T. brucei* AnTat1.1 90:13 PFR-Ty1 cells ([Figure 4c](#F4){ref-type="fig"}). However, with *Tb*HYP2 silencing, the prevalence of PAD1-positive *T. brucei* cells was significantly less (p\<0.0001) ([Figure 4f](#F4){ref-type="fig"}, [Supplementary Figure 10](#SD2){ref-type="supplementary-material"}) as was the accumulation of cells with 1K1N (p=0.007; [Supplementary Figure 11](#SD2){ref-type="supplementary-material"}), despite equivalent numbers of *T. brucei* in each infection. Hence, co-infection with *T. congolense* induces *T. brucei* to generate stumpy forms at low relative parasitaemia, with dependence upon integrity of the *T. brucei* QS signalling pathway demonstrating that this is mediated through QS cross-talk between the species *in vivo*.

In combination, our results have established, firstly, that *T. congolense* is capable of density sensing *in vivo*, generating cell-cycle arrested forms akin to the stumpy forms of *T. brucei*, albeit without significant morphological transformation. Secondly, and consistent with this, the genome of the parasite encodes many molecules with similarity to components previously implicated in *T. brucei* QS responses, at least one of which can functionally complement a *T. brucei* null mutant to rescue stumpy formation. Moreover, 8-pCPT-cAMP which mimics the QS signal in *T. brucei*, also promotes growth inhibition in *T. congolense* supporting conservation of the signalling pathway. Finally, we have demonstrated that *T. congolense* can generate a QS signal that drives *T. brucei* stumpy formation *in vitro* and during co-infections, and that this effect is lost when the *T. brucei* QS signalling pathway is silenced, demonstrating transduction via the same molecular pathway as the *T. brucei* QS signal. This demonstrates the capacity for inter-species QS between *Trypanosoma congolense* and *Trypanosoma brucei* in simultaneously infected hosts. Interestingly, our results provide clear evidence of *T. congolense* signalling to *T. brucei* but the converse was less obvious. Whether this indicates that signalling is unidirectional or whether our culture adapted *T. congolense* line are less sensitive to the QS signal remains to be established.

Trypanosome infections are sustained long-term in mammalian hosts in the field, such that the capacity for interaction within and between species in co-infections has the potential to generate distinct evolutionary responses[@R22],[@R23]. For example, the production of a co-received QS signal may favour a pre-existing parasite population by preventing a secondary incoming trypanosome species proliferating and so establishing, a feature described in malaria infections[@R24],[@R25]. Reduced sensitivity to the shared QS signal may also be selected in the context of an established co-infection to improve competitive fitness. Finally, if production of the QS signal was resource costly, cheats that produce less signal could exploit that of the co-infecting parasites to assist their transmissibility[@R26],[@R27]. These scenarios may each select parasites whose capacity for virulence and transmissibility is adapted to the presence of a competing species. However, if transferred to naive hosts without competitors, parasites adapted for co-infection might exhibit a different infection dynamic, potentially exhibiting enhanced virulence through their reduced sensitivity to QS signals. As well as *T. brucei brucei*, that can only infect animals, livestock and game animals are the long-term reservoir of human infective *Trypanosoma brucei rhodesiense*[@R28] and, potentially, *Trypanosoma brucei gambiense*. Where human infective *T. brucei* coexist with *T. congolense*, the transition from long-term maintenance in a co-infected game reservoir into a monospecies infection in a human host may contribute, with host factors and other parasite factors, to the variability in parasite burden generated by different parasite isolates[@R29],[@R30].

Methods {#S1}
=======

Animal experiments {#S2}
------------------

Animals were allocated at random into treatment groups from a group of female, age matched adult MF1 mice, at least 10 weeks old. No blinding was done.

*T. congolense* IL3000 infections {#S3}
---------------------------------

*T. congolense* parasites of the IL3000 strain were used both for infections and *in vitro* experiments. This strain was derived from the ILC-49 strain that was isolated from a cow in the Trans Mara, Kenya[@R31]. The *T. congolense* IL3000 parasites used for *in vivo* experiments were provided by Dr Annette MacLeod (University of Glasgow) in a blood straw. The *T. congolense* IL3000 parasites used for *in vitro* experiments were supplied as culture-adapted bloodstream forms by Dr Liam Morrison (Roslin Institute, Edinburgh), who had received them from Professor Théo Baltz (University of Bordeaux). Six female MF1 mice were inoculated intraperitoneally with *T. congolense* ILTat3000. Parasitaemia was monitored daily from day 3 post-infection. Parasitaemia was estimated from a wet blood smear using the Herbert and Lumsden rapid matching method[@R32]. Air-dried blood smears were fixed in ice-cold methanol and stored at -20**°**C prior to cell cycle analysis.

*T. brucei* null mutant infections {#S4}
----------------------------------

Three female cyclophosphamide-treated MF1 mice were inoculated intraperitoneally with the *Tb*Hyp2 null mutant cell line. In parallel two mice were inoculated with the parental AnTat1.1 90:13 cell line. Parasitaemia was monitored daily from day 3 post-infection. Parasitaemia was estimated from a wet blood smear using the Herbert and Lumsden rapid matching method[@R32]. Infections were monitored until parasites differentiated to stumpy forms or were terminated if the uncontrolled ascending parasitaemia was predicted to become lethal within the next 12 hours. At the end of the experiment parasites were purified from whole blood by passage through a DE52 column (Whatman^**®**^ anion exchange cellulose, Z742600) at pH 7.8.

Infections to test functional complementation {#S5}
---------------------------------------------

Six female cyclophosphamide-treated MF1 mice were inoculated intraperitoneally with the *Tc*Hyp2 overexpression *Tb*Hyp2 null mutant cell line. One group (n=3) was provided with doxycycline (200μg/ml in 5% sucrose) in their drinking water from the time of inoculation to induce *Tc*Hyp2 overexpression. The other group (n=3) received 5% sucrose only. In parallel one mouse was infected with AnTat1.1 90:13 and one mouse with the *Tb*HYP2 null mutant. Parasitaemia was monitored daily from day 3 post-infection. Parasitaemia was estimated from a wet blood smear using the Herbert and Lumsden rapid matching method[@R32]. Infections were monitored until parasites differentiated to stumpy forms or were terminated if the uncontrolled ascending parasitaemia was predicted to become lethal within the next 12 hours. At the end of the experiment parasites were purified from whole blood by passage through a DE52 column (Whatman^**®**^ anion exchange cellulose, Z742600) at pH 7.8.

Cell cycle analysis {#S6}
-------------------

Methanol-fixed blood smears were rehydrated in PBS for 5 min. Slides were stained with 30μl of DAPI (10μg/ml in PBS) for 2 min in a humidity chamber and were then washed for 5 min in PBS. Slides were then mounted with 40μl Mowiol containing 2.5% DABCO (1, 4-diazabicyclo\[2.2.2\]octane). Nucleus and kinetoplast configurations were recorded by manual cell counting. 500 cells were counted per sample and per timepoint except where there was very low parasitaemia, where 200 cells were counted.

Generation of a *Tb*HYP2 null mutant with inducible *Tc*HYP2 overexpression {#S7}
---------------------------------------------------------------------------

pEnT6B-Y and pEnT6P-Y vectors[@R33] were used to generate the *Tb*HYP2 null mutant by sequential allelic replacement. Primers were designed to amplify regions of the 5'UTR and 3'UTR of *Tb*HYP2 in order to replace the endogenous gene with a cassette containing either a puromycin or blasticidin resistance marker. Constructs were used to transfect the pleomorphic AnTat1.1 90:13 cell line, and successful generation of a null mutant was confirmed by Southern blotting.

Primers (F primer: GGGTTTACTAGTATGGCCTCAGAGTCAGCG, R primer: GGGTTTGGATCCCTACCCCCGTCCCTGTCC) were designed to amplify *Tc*Hyp2 (*Tc*IL3000.0.19510) with appropriate terminal restriction sites for insertion into the pDex577-Y vector for tetracycline-inducible overexpression with an N-terminal TY epitope tag[@R21]. The overexpression construct was used to transfect the *Tb*HYP2 null mutant and inducible overexpression was confirmed by Western blotting using an anti-TY antibody (BB2[@R21]).

Southern blotting {#S8}
-----------------

A gene probe was produced to detect the presence of the *Tb*HYP2 gene and a 5'UTR probe was designed to detect the correct integration of both constructs. PCR reactions with Q5 high fidelity DNA polymerase (NEB, M0491S) were used to generate material for the 5'UTR probe (F primer: ACTAGTACATGCTGGTCGTCAGTATT, R primer: GGATCCATCAGTGCACGTATTCTACCA) and gene probe (F primer: GGGTTTACTAGTATGGCATCGGAGGCAGCG, R primer: GGGTTTGGATCCTTATTCGCCCCTAACTGC). Purified DNA was then used to generate DIG-labelled probes with the DIG High Prime labelling and detection starter kit II (Roche, 11585614910). 1μg of genomic DNA extracted from parental AnTat1.1 90:13 cells, cells with suspected single allelic replacement of *Tb*Hyp2 and cells with suspected double allelic replacement of *Tb*Hyp2 was digested overnight at 37**°**C by PstI (Promega, R6111). Digested DNA was divided between two lanes (one for each probe) and resolved on an agarose gel for 3h at 100V. The gel was then soaked successively in depurination solution (0.25M HCl), denaturation solution (1.5M NaCl/0.5M NaOH) and neutralisation solution (1M Tris/1.5M NaCl/pH7.4) prior to transfer of the DNA to a nylon membrane overnight. The membrane was then UV cross-linked. Hybridisation was carried out overnight at 42**°**C with the DIG-labelled DNA probe in DIG Easy Hyb Buffer (Roche, 11603558001). The membrane was washed twice for 5 min in 2xSSC/0.1%SDS at RT, and then twice for 15 min on 0.5xSSC/0.1%SDS at 68**°**C. The membrane was blocked for 1h with Maleic acid buffer containing 1% DIG block, before addition of 2μl anti-DIG (Roche, 11093274910) and incubation for 30 min. Final detection used the chemiluminescent substrate CDP-Star (Roche, 11685627001) diluted 1:100 in detection buffer (100mM Tris HCl 100mM NaCl pH9.5).

Western blotting {#S9}
----------------

Protein samples were resolved on SDS-PAGE gels and blotted onto nitrocellulose membrane. Primary antibody dilutions were prepared in 5% milk and the membrane was incubated overnight. αBB2 antibody[@R21] was used at 1:20 to detect the TY-tagged *Tc*Hyp2, αPAD1 antibody[@R16] was used at 1:1000. αG6PDH (glucose-6-phosphate dehydrogenase, kind gift of Professor Paul Michels, University of Edinburgh) was used for loading controls at 1:10,000, and αEF1 (elongation factor 1-alpha, Merck Millipore 05-235) was used for loading controls at 1:7000. Secondary antibodies were diluted in 50% PBS and 50% Li-cor blocking buffer. Both anti-mouse (IRDye® 680 goat anti-mouse, Li-cor) and anti-rabbit (goat anti-rabbit IgG (H+L) Dylight 800, Thermoscientific) secondary antibodies were diluted 1:7500. Immunofluorescence was detected on the Li-cor Odyssey imaging system.

*In vitro* differentiation to procyclic forms {#S10}
---------------------------------------------

Parasites were resuspended at 2x10^6^/ml in SDM79 medium (GIBCO by Life technologies) containing 6mM cis-aconitate (Sigma, A3412) and were incubated at 27**°**C. Samples were collected for flow cytometry at 0h, 4h and 24h.

Flow cytometry {#S11}
--------------

2-5x10^6^ cells were washed twice in PBS prior to fixing in 500μl 2% formaldehyde/0.05% glutaraldehyde \>1h at 4**°**C. Cells were then washed 3x in PBS and resuspended in 2%BSA:PBS for 30 min. Cells were then resuspended in primary antibody diluted in 2%BSA:PBS (αPAD1 was diluted 1:200, αEP procyclin (Cedar Lane laboratories) was diluted 1:500) and were incubated overnight at 4**°**C. The cells were washed twice in PBS and were resuspended in secondary antibody diluted in 2%BSA:PBS (α-rabbit CY5 and α-mouse FITC were each diluted 1:1000). The cells were washed twice in PBS and were resuspended in 500μl PBS containing 0.02μg/ml DAPI. Samples were then processed on an LSRII flow cytometer (BD Biosciences). Positive controls and secondary antibody only controls were included. Analysis was performed using FlowJo software (Tree Star).

Conditioned medium generation {#S12}
-----------------------------

For generation of conditioned medium, cultures of *T. brucei* AnTat1.1 90:13 were established at 1x10^5^cells/ml in HMI-9[@R34] and were incubated for 2 days at 37°C (and 5%CO~2~). Conditioned medium was harvested when cells had reached a density of 2-3x10^6^/ml, by pelleting the cells and passing the supernatant through a 0.22μm filter. Filtered supernatant was stored at 4°C. Cultures of *T. congolense* for generating conditioned medium were in most cases established at 1x10^5^ cells/ml in *Tc*BSF3[@R17] and were incubated for 3 days at 34°C (and 5%CO~2~). Conditioned medium was collected at a range of densities from 5x10^6^ cells/ml to 1x10^7^ cells/ml, and prepared as for *T. brucei* conditioned medium by filtering of conditioned supernatant through a 0.22μm filter. Conditioned medium was stored for a maximum of 5 days at 4°C before use. Alongside flasks for conditioned medium generation, flasks containing either HMI-9 or *Tc*BSF3 without parasites were prepared, and this control medium was treated in the same way as the conditioned medium and used as a negative control in all conditioned medium experiments.

CAT reporter experiments {#S13}
------------------------

A pleomorphic cell line with a CAT reporter under the control of the PAD1 3'UTR was used to report on stumpy formation[@R19]. Additionally, a pleomorphic cell line with inducible *Tb*HYP2 RNAi[@R15] was transfected with the CAT PAD1 3'UTR construct or a control construct with CAT reporter expression controlled by the 3'UTR of the constitutively expressed aldolase gene[@R19].

The CAT reporter *T. brucei* cells were washed once with HMI-9 and resuspended at a density of 2x10^5^ cells/ml in a mixture of 75% conditioned medium or control medium and 25% HMI-9. Cultures were incubated for 3 days at 37**°**C (and 5%CO~2~) without passage. Each day cell number was estimated using a Beckman Coulter Z2 Coulter Particle count and size analyser (or haemocytometer if there were a number of dead cells), and CAT ELISA samples were collected. For experiments involving Hyp2 RNAi, induction of the RNAi with doxycycline was initiated one day before the addition of conditioned medium, and was maintained throughout the experiment. CAT ELISA samples were prepared by collecting 5ml of culture, washing cells 3x with PBS, and resuspending in 1ml CAT lysis buffer (Roche) for 25 min at RT. The lysis reaction was centrifuged to pellet debris and the supernatant was snap frozen in liquid nitrogen and stored at -80**°**C.

Samples were analysed by CAT ELISA (Roche, 11363727001) to determine their CAT concentration according to the manufacturer's instructions. Each sample was loaded into two wells of a 96 well plate. The CAT concentration of the samples was estimated by comparing the absorbance at 405nm to that of a CAT standard curve (provided by the manufacturer). The standard curve included a range of CAT concentrations of 0.0625ng/ml CAT to 2ng/ml CAT, as well as a blank of 0ng/ml. Absorbance was measured using a BioTek ELx808 Absorbance Microplate reader with Gen5 data analysis software (BioTek). Reads of duplicate wells at 405nm were averaged and converted to CAT concentrations using the standard curve. CAT concentration/ cell was calculated using the number of cells in each 5ml sample collected during the experiment.

Superinfection experiment {#S14}
-------------------------

Six female MF1 mice were inoculated intraperitoneally with *T. congolense* ILTat3000 on day 0, each mouse received approximately 2.4x10^6^ cells. On day 4, three *T. congolense*-infected and three previously uninfected mice were inoculated intraperitoneally with *T. brucei* AnTat1.1 90:13 with a TY-tagged PFR, each mouse received approximately 1.2x10^5^ cells. Stocks used for infection were mixed prior to division between mice to ensure that single species infections and co-infections were initiated with the same *T. brucei* inoculum.

Parasitaemia was monitored daily from day 4 post-infection. Total parasitaemia was estimated from a wet blood smear using the Herbert and Lumsden rapid matching method[@R32]. 10μl of blood was collected on each day of infection, and cells were washed in 200μl cold PSG and resuspended in 125μl cold PBS, and then 125μl 8% paraformaldehyde in PBS was added. Cells were fixed on ice for 10 min and then resuspended in 130μl 0.1M glycine in PBS, and kept at 4**°**C overnight. Samples were then resuspended in PBS and used for immunofluorescence. The proportion of the co-infection parasitaemia contributed by each species was estimated by counting the number of PFR-TY1 positive cells (\>2000 cells scored). At the end of the experiment parasites were purified from whole blood by passage through a DE52 column (Whatman^**®**^ anion exchange cellulose, Z742600) at pH 7.8. Purified parasites were paraformaldehyde fixed for immunofluorescence and these samples were used to determine the proportion of *T. brucei* that were PAD1 positive in the infections (\>500 cells scored), as well as the KN configuration of these cells.

Superinfection experiment with *Tb*HYP2 RNAi induction {#S15}
------------------------------------------------------

Six female MF1 mice were inoculated intraperitoneally with *T. congolense* ILTat3000 on day 0, each mouse received approximately 2.4x10^6^ cells. On day 4, all six *T. congolense*-infected and six previously uninfected mice were inoculated intraperitoneally with a *T. brucei* EATRO1125 AnTat1.1 90:13 cell line with a TY-tagged PFR and doxycycline-inducible RNAi targeting *Tb*HYP2, each mouse received approximately 1.2x10^5^ cells. Stocks used for infection were mixed prior to division between mice to ensure that all infections were initiated with the same *T. brucei* inoculum.

On day 1 of the experiment doxycycline (200μg/ml in 5% sucrose) was provided in the drinking water of three of the *T. congolense* infected mice and three of the uninfected mice, the remaining mice received 5% sucrose only. Parasitaemia was monitored and samples were collected as for the initial superinfection experiment.

Immunofluorescence {#S16}
------------------

Paraformaldehyde fixed cells were adhered to Polysine**®** slides (VWR, 631-0107). 20μl 0.1% triton in PBS was applied to each well for 2 minutes, this was then aspirated and wells were washed with a large drop of PBS. Wells were blocked with 2% BSA:PBS for 45 minutes at 37**°**C in a humidity chamber, before application of 20μl primary antibody. Wells were incubated with primary antibody (diluted in 2% BSA:PBS, αPAD1 1:1000, BB2 1:20) for 45 minutes at 37**°**C in a humidity chamber. Positive control wells and secondary antibody only wells were included for each experiment. Wells were each washed 5 times by repeatedly applying and aspirating 1x PBS. Wells were incubated with 20μl secondary antibody (diluted in 2% BSA:PBS, α-rabbit Alexa fluor 488 1:500, α-mouse Alexa fluor 568 1:500) for 45 minutes at 37**°**C in a humidity chamber. 20μl of a DAPI working dilution (10μg/ml in PBS) was then applied to each well for 1 minute, followed by 5 washes with PBS. Slides were mounted with a cover slip by application of Mowiol containing 2.5% DABCO. Slides were analysed on a Zeiss Axioskop 2 plus or Zeiss Axio Imager Z2, and QCapture software was used for image capture. Images of BB2, PAD1 and DAPI staining were overlaid in ImageJ 64[@R35] and cell counts were performed using the Cell Counter Plugin.

Bioinformatic analysis {#S17}
----------------------

The BLASTP tool on TritrypDB[@R36] was used for identification of orthologues.

Statistical analysis {#S18}
--------------------

Most statistical analyses were carried out in GraphPad Prism version 6 (GraphPad Software, La Jolla, California, USA, [www.graphpad.com](http://www.graphpad.com/)). A General Linear Model was used to analyse *T. congolense* parasitaemias for cell cycle arrest using Minitab®. This model tested the significance of the effect of parasitaemia on % 2K1N, 2K2N cells and incorporated mouse as a random factor, which was not significant (p=0.55) In all analyses a p-value \<0.05 was considered significant. Where the analyses used work on the assumption of a normal distribution, the distribution of the data was assessed before performing the analyses, and if required the data was transformed prior to testing.

Animal studies and group sizes {#S19}
------------------------------

Animal experiments were carried out according to the UK Animals (Scientific) Procedures act under a licence (PPL60/4373) issued by the UK Home Office and approved by the University of Edinburgh Local ethical committee.

For the analysis of phenotypes 3- 5 animals per treatment were routinely used for analysis. Our previous analyses (e.g. Mony, B.M., et al., Genome-wide dissection of the quorum sensing signalling pathway in Trypanosoma brucei. Nature, 2014. 505(7485): p. 681-5)[@R15] indicate that this sample size is sufficient to detect differences between cell lines and treatment groups (for example where gene silencing is activated by provision of doxycycline). Using that data as an exemplar, we tested 5 genes for effects with and without doxycycline mediated gene-silencing *in vivo*. Using cell cycle status as the measured parameter, the effect size ranged from 0.637 to 1.804. Those values were then used to calculate the power for different samples sizes. This showed that a sample size of 3-5 per group (+ or - DOX), or total of 6 to 10 allowed us to achieve 80% power for all test genes except one. In our current manuscript, the visual analytical assays applied (manual scoring by microscope) to the different treatments and groups (cell cycle scoring, analysis of PAD1 staining, scoring of flagellar labelling for parasite species, morphological analysis) required analyses to be limited to 3 animals per group. Data were examined before analysis to ensure normality and that no transformations were required. P values of less than 0.05 were considered statistically significant.
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**Supplementary Information** is linked to the online version of the paper at [www.nature.com/naturemicrobiology](https://www.nature.com/nmicrobiol/)
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![*T. congolense* cell cycle analysis reveals a reduction in proliferating cells at the peak of parasitaemia.\
a) Cell cycle analysis over the first 14 days of infection for six mice infected with *T. congolense* ILTat3000. The slope of the percentage of proliferating cells (2K1N -- G2-phase cells, 2K2N -- post-mitotic cells) and the parasitaemia showed significant deviation from zero (p=0.0003). 500 parasites were scored per sample unless parasitaemias were very low, when 200 cells were scored.\
b) Phase contrast images of *T. brucei* slender (3 days post infection) and stumpy forms (6 days post infection) (top) and *T. congolense* ILTat3000 over 7 days of infection. Cells were counterstained with DAPI to reveal the nucleus and kinetoplast. Scale bar= 10µm.\
c) Forward and side scatter profiles of slender (3 days post infection, n=2) and stumpy form (6 days post infection, n=2) parasites highlighting morphological differences between the developmental forms.\
d) Forward and side scatter profiles of *T. congolense* ILTat3000 during ascending parasitaemia (5 days post infection, n=2) or at the first peak of parasitaemia (7 days post infection, n=2). Inset images show the absence of morphological difference between each population. Scale bar= 10µm.](emss-73570-f001){#F1}

![A *T. congolense* orthologue of a *T. brucei* QS response pathway component, *Tb*HYP2, can restore stumpy formation in a *T. brucei Tb*HYP2 null mutant in murine infections.\
a) A *T. brucei* EATRO 1125 *Tb*Hyp2 null mutant was generated by sequential allelic replacement in the parental cell line *T. brucei* AnTat1.1 90:13. The *Tb*Hyp2 null mutant (*T. brucei* AnTat1.1 90:13 *Tb*HYP2 dKO) was then transfected with a construct for the doxycycline-inducible ectopic expression of *Tc*HYP2 (*Tc*HYP2 OE in KO).\
b) Growth of the *T. brucei* EATRO 1125 *Tb*Hyp2 null mutant cell line with doxycycline-inducible TcHYP2 expression (TcHyp2 OE in KO) in mice. Parasite population growth was limited in infections where *Tc*HYP2 ectopic expression was induced (+Dox, red lines, n=3) relative to uninduced controls (-Dox, blue lines, n=3). Parental *T. brucei* AnTat 1.1 90:13 (black line, n=1) and *T. brucei* EATRO 1125 *Tb*HYP2 null mutant (navy line, n=1) cell lines were included as controls (further replicates are provided in [Supplementary Figure 4](#SD2){ref-type="supplementary-material"}). Crosses indicate humane euthanasia when infections were anticipated to be lethal within 12 hours.\
c) Expression of the stumpy marker PAD1 was higher when *Tc*HYP2 was ectopically expressed in the *T. brucei* EATRO 1125 *Tb*Hyp2 null mutant than in the uninduced control. TY1-tagged *Tc*HYP2 protein was detected with BB2 antibody in +Dox samples but not in --Dox samples. Glucose-6-phosphate dehydrogenase, loading control.\
d) Cells induced to express *Tc*HYP2 (+Dox, n=3) had increased capacity to differentiate to procyclic forms relative to uninduced cells (-Dox, n=3) following treatment with cis-aconitate, as determined by EP procyclin expression at 4h and 24h after treatment (unpaired t test, ★★★★p\<0.0001, ★★p\<0.01, two-sided). Bars represent mean ± SD). Parental *T. brucei* AnTat 1.1 90:13 stumpy (green, n=1) and culture-derived slender (orange, n=2) cells, as well as *T. brucei* EATRO 1125 *Tb*HYP2 null mutant (navy, n=1) cells were included as controls. Culture-derived procyclic cells (purple, n=1) were used as a positive control for procyclin expression.](emss-73570-f002){#F2}

![Treatment with *T. brucei-* or *T. congolense-* conditioned medium inhibits growth of pleomorphic *T. brucei* via QS-signalling.\
a) A pleomorphic *T. brucei* cell line (EATRO 1125) with a CAT reporter under the control of the PAD1 3'UTR (*T. brucei* AnTat1.1 90:13 CAT-PAD) was used to report on stumpy formation in response to conditioned medium treatment. Growth of this cell line was inhibited by treatment with 75% *T. brucei*-(*Tb*CM) or 75% *T. congolense-* (*Tc*CM) conditioned medium relative to non-conditioned control media (*Tb*N and *Tc*N). Data points represent the mean ± SEM of n=3 flasks.\
b) CAT concentration/cell was elevated after 1 or 2 days of treatment with *Tb*CM or *Tc*CM (unpaired t test, ★p\<0.05, ★★★p\<0.001, two-sided). Bars represent mean ± SD of n=3 flasks. The effect of *Tc*CM was reproducible in three (out of three) independent experiments (one representative experiment is shown). The negative controls expressed an elevated CAT concentration/cell on day 3 because cultures were maintained without passage such that cell growth caused accumulation of the QS signal.\
c) A CAT PAD 3'UTR reporter construct was transfected into a pleomorphic cell line (*T. brucei* EATRO 1125 AnTat1.1 90:13) with the capacity for doxycycline-inducible knock down of the QS-signalling component *Tb*HYP2 (*T. brucei* AnTat1.1 90:13 CAT-PAD *Tb*HYP2 RNAi). When this cell line was treated with *Tb*CM, the increase in CAT concentration/cell was muted in cells where *Tb*HYP2 RNAi had been induced relative to uninduced cells. Bars represent the mean ± SEM of n=3 flasks.\
d) When the same cell line was treated with *Tc*CM, the increase in CAT concentration/cell was diminished in cells where *Tb*HYP2 RNAi had been induced relative to uninduced cells. Comparisons between categories were made using two-way ANOVA followed by Tukey's multiple comparison test (★p\<0.05, ★★p\<0.01, ★★★p\<0.001, ★★★★p\<0.0001). Bars represent the mean ± SEM of n=3 flasks. The effect of *Tc*CM and *Tb*CM on this cell line was reproducible in two (out of two) independent experiments (one representative experiment is shown).](emss-73570-f003){#F3}

![Pleomorphic *T. brucei* introduced into an established *T. congolense* infection differentiate prematurely to stumpy forms in an effect mediated by QS-signalling.\
a) Pleomorphic *T. brucei* EATRO 1125 encoding Ty1 epitope-tagged PFRA (*T. brucei* AnTat1.1 90:13 PFR-Ty1) were used to identify *T. brucei in* mixed infections by flagellar staining (green). Note that *T. congolense* cells show non-specific intracellular staining with the BB2 antibody that detects the Ty1 epitope. A PAD1-positive *T. brucei* stumpy cell (arrowhead) is shown surrounded by *T. congolense* cells on day 8 of the co-infection experiment. PAD1-red. DAPI-purple. Scale bar, 10µm.\
b) The proportion of each parasite species was determined by scoring \>2000 cells in the co-infections as PFR-Ty1 positive or negative, and applied to the total parasitaemia to calculate the effective parasitaemia of each species in the co-infections on days 6, 7 and 8. The effective *T. brucei* parasitaemia in the co-infections (purple, n=3) remained lower than in the control '*T. brucei* only' infections (blue, n=3). Green; *T. congolense* in the co-infections (n=3). Red; '*T. congolense* only' infections (n=3).\
c) PAD1-positive *T. brucei* on day 8 of the experiment (\>500 cells scored, n=3 for each condition tested). Despite lower *T. brucei* parasitaemia in the superinfections there was a higher percentage of PAD1-positive cells compared with the single species *T. brucei* infections (unpaired t test, ★★p\<0.01, two-sided). Error bars represent mean ± SD.\
d) A cell line with a Ty1 epitope tagged PFRA protein and the capacity for doxycycline-inducible *Tb*HYP2 RNAi was generated. Effective RNAi targeting *Tb*HYP2 was confirmed by Northern blot using RNA collected after 48 hours of culture ± doxycycline. Ethidium bromide stained rRNA acts a loading control.\
e) The proportion of parasites of each species was calculated as in the panel b (n=3 for each condition tested). The effective *T. brucei* parasitaemia was lower in superinfections than in '*T. brucei* only' infections, whether or not *Tb*HYP2 RNAi was induced. The effective *T. brucei* parasitaemia was higher in co-infections where *Tb*Hyp2 RNAi was induced (+Dox) than those without induction (-Dox), though the difference was not significant.\
f) PAD1-positive *T. brucei* on day 8 of the experiment (\>500 cells scored, n=3 for each condition tested). There were significantly more PAD1-positive *T. brucei* cells in the co-infections where *Tb*Hyp2 RNAi was not induced (30-45%) than in co-infections where *Tb*HYP2 RNAi was induced (1-3%) (★★★★p\<0.0001, One-way ANOVA with Tukey's multiple comparisons test). Error bars represent mean ± SD.](emss-73570-f004){#F4}
